Robert W.A. Sellers - May 7, 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
SVP, Corporate Controller
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
May 7, 2024
Transactions value $
-$15,146
Form type
4
Date filed
5/9/2024, 07:38 PM
Previous filing
May 6, 2024
Next filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Award $0 +2.45K +16.25% $0.00 17.5K May 7, 2024 Direct F1
transaction EW Common Stock Tax liability -$15.1K -178 -1.02% $85.09 17.3K May 7, 2024 Direct
holding EW Common Stock 20.4K May 7, 2024 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Award $0 +4.82K $0.00 4.82K May 7, 2024 Common Stock 4.82K $85.84 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
F2 These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.